- Molecular Dimensions of Gastric Cancer: Translational and Clinical Perspectives
-
Yoon Young Choi, Sung Hoon Noh, Jae-Ho Cheong
-
J Pathol Transl Med. 2016;50(1):1-9. Published online October 26, 2015
-
DOI: https://doi.org/10.4132/jptm.2015.09.10
-
-
13,738
View
-
156
Download
-
21
Web of Science
-
22
Crossref
-
 Abstract
 PDF
- Gastric cancer is a global health burden and has the highest incidence in East Asia. This disease is complex in nature because it arises from multiple interactions of genetic, local environmental, and host factors, resulting in biological heterogeneity. This genetic intricacy converges on molecular characteristics reflecting the pathophysiology, tumor biology, and clinical outcome. Therefore, understanding the molecular characteristics at a genomic level is pivotal to improving the clinical care of patients with gastric cancer. A recent landmark study, The Cancer Genome Atlas (TCGA) project, showed the molecular landscape of gastric cancer through a comprehensive molecular evaluation of 295 primary gastric cancers. The proposed molecular classification divided gastric cancer into four subtypes: Epstein-Barr virus–positive, microsatellite unstable, genomic stable, and chromosomal instability. This information will be taken into account in future clinical trials and will be translated into clinical therapeutic decisions. To fully realize the clinical benefit, many challenges must be overcome. Rapid growth of high-throughput biology and functional validation of molecular targets will further deepen our knowledge of molecular dimensions of this cancer, allowing for personalized precision medicine.
-
Citations
Citations to this article as recorded by  - Establishment and characterization of a new mouse gastric carcinoma cell line, MCC
Yushen Wang, Xianju Li, Yi Wang, Jun Qin
Cancer Cell International.2025;[Epub] CrossRef - Advancements and challenges in gastric cancer: epidemiology, biomarkers, and therapeutic strategies
Marina Nishimuni, Laura Carolina Lopez Claro, Maria Ignez Freitas Melro Braghiroli
Surgical and Experimental Pathology.2024;[Epub] CrossRef - Tissue Biomarkers in Gastric Cancer Treatment: Present and Future
Giulia Airò, Virginia Agnetti, Fabiana Pratticò, Marianna Peroni, Simona Bui, Giovanni Mura, Maria Urbanowicz-Nijaki, Eleonora Lai, Marco Puzzoni, Fabiana Contu, Nerina Denaro, Mario Scartozzi, Cinzia Solinas, Chiara Tommasi
International Journal of Translational Medicine.2024; 4(4): 640. CrossRef - Research Progress of MSI Gastric Cancer Subtypes
成菊 马
Advances in Clinical Medicine.2022; 12(07): 6719. CrossRef - OCT4-mediated transcription confers oncogenic advantage for a subset of gastric tumors with poor clinical outcome
Jaishree Pandian, Ponmathi Panneerpandian, Balaji T. Sekar, Karthikeyan Selvarasu, Kumaresan Ganesan
Functional & Integrative Genomics.2022; 22(6): 1345. CrossRef - Secondary Primary Cancer after Primary Gastric Cancer: Literature Review and Big Data Analysis Using the Health Insurance Review and Assessment Service (HIRA) Database of Republic of Korea
Jeong Ho Song, Yeonkyoung Lee, Jaesung Heo, Sang-Yong Son, Hoon Hur, Sang-Uk Han
Cancers.2022; 14(24): 6165. CrossRef - Microsatellite instability: a review of what the oncologist should know
Kai Li, Haiqing Luo, Lianfang Huang, Hui Luo, Xiao Zhu
Cancer Cell International.2020;[Epub] CrossRef - Single Patient Classifier Assay, Microsatellite Instability, and Epstein-Barr Virus Status Predict Clinical Outcomes in Stage II/III Gastric Cancer: Results from CLASSIC Trial
Chul Kyu Roh, Yoon Young Choi, Seohee Choi, Won Jun Seo, Minah Cho, Eunji Jang, Taeil Son, Hyoung-Il Kim, Hyeseon Kim, Woo Jin Hyung, Yong-Min Huh, Sung Hoon Noh, Jae-Ho Cheong
Yonsei Medical Journal.2019; 60(2): 132. CrossRef - Ten Thousand Consecutive Gastrectomies for Gastric Cancer: Perspectives of a Master Surgeon
Yoon Young Choi, Minah Cho, In Gyu Kwon, Taeil Son, Hyoung-Il Kim, Seung Ho Choi, Jae-Ho Cheong, Woo Jin Hyung
Yonsei Medical Journal.2019; 60(3): 235. CrossRef - Clinicopathologic significance of human leukocyte antigen class I expression in patients with stage II and III gastric cancer
Yujun Park, Jiwon Koh, Yoonjin Kwak, Sang-Hoon Ahn, Do Joong Park, Hyung-Ho Kim, Woo Ho Kim, Hye Seung Lee
Cancer Immunology, Immunotherapy.2019; 68(11): 1779. CrossRef - Phosphoproteomics Enables Molecular Subtyping and Nomination of Kinase Candidates for Individual Patients of Diffuse-Type Gastric Cancer
Mengsha Tong, Chunyu Yu, Jinwen Shi, Wenwen Huang, Sai Ge, Mingwei Liu, Lei Song, Dongdong Zhan, Xia Xia, Wanlin Liu, Jinwen Feng, Wenhao Shi, Jiafu Ji, Jing Gao, Tieliu Shi, Weimin Zhu, Chen Ding, Yi Wang, Fuchu He, Lin Shen, Tingting Li, Jun Qin
iScience.2019; 22: 44. CrossRef - Trastuzumab Specific Epitope Evaluation as a Predictive and Prognostic Biomarker in Gastric Cancer Patients
Jiwon Koh, Soo Kyung Nam, Youn Woo Lee, Jin Won Kim, Keun-Wook Lee, Chan-Young Ock, Do-Youn Oh, Sang-Hoon Ahn, Hyung-Ho Kim, Keon-Wook Kang, Woo Ho Kim, Ho-Young Lee, Hye Seung Lee
Biomolecules.2019; 9(12): 782. CrossRef - Targeted drug delivery of capecitabine to mice xenograft gastric cancer by PAMAM dendrimer nanocarrier
Sharareh Jafari, Fatemeh Nabavizadeh, Jalal Vahedian, Mehdi Shafie Ardestani, Hedayat Samandari, Ali Zare Mehrjerdi
african journal of gastroenterology and hepatology.2019; 2(1): 28. CrossRef - New therapeutic options opened by the molecular classification of gastric cancer
Mihaela Chivu-Economescu, Lilia Matei, Laura G Necula, Denisa L Dragu, Coralia Bleotu, Carmen C Diaconu
World Journal of Gastroenterology.2018; 24(18): 1942. CrossRef - Proposed Molecular and miRNA Classification of Gastric Cancer
Lara Alessandrini, Melissa Manchi, Valli De Re, Riccardo Dolcetti, Vincenzo Canzonieri
International Journal of Molecular Sciences.2018; 19(6): 1683. CrossRef - High serum MMP-14 predicts worse survival in gastric cancer
Aaro Kasurinen, Taina Tervahartiala, Alli Laitinen, Arto Kokkola, Timo Sorsa, Camilla Böckelman, Caj Haglund, Dajun Deng
PLOS ONE.2018; 13(12): e0208800. CrossRef - miR-30 functions as an oncomiR in gastric cancer cells through regulation of P53-mediated mitochondrial apoptotic pathway
Jianjun Wang, Yang Jiao, Lunmeng Cui, Lili Jiang
Bioscience, Biotechnology, and Biochemistry.2017; 81(1): 119. CrossRef - Clinicopathologic implication of meticulous pathologic examination of regional lymph nodes in gastric cancer patients
Jiwon Koh, Hee Eun Lee, Woo Ho Kim, Hye Seung Lee, Ju-Seog Lee
PLOS ONE.2017; 12(3): e0174814. CrossRef - Perioperative chemotherapy for resectable gastric cancer – what is the evidence?
Erling A Bringeland, Hans H Wasmuth, Jon E Grønbech
Scandinavian Journal of Gastroenterology.2017; 52(6-7): 647. CrossRef - Molecular classifications of gastric cancers: Novel insights and possible future applications
Silvio Ken Garattini, Debora Basile, Monica Cattaneo, Valentina Fanotto, Elena Ongaro, Marta Bonotto, Francesca V Negri, Rosa Berenato, Paola Ermacora, Giovanni Gerardo Cardellino, Mariella Giovannoni, Nicoletta Pella, Mario Scartozzi, Lorenzo Antonuzzo,
World Journal of Gastrointestinal Oncology.2017; 9(5): 194. CrossRef - GRAM domain-containing protein 1B (GRAMD1B), a novel component of the JAK/STAT signaling pathway, functions in gastric carcinogenesis
Puja Khanna, Pei Jou Chua, Belinda Shu Ee Wong, Changhong Yin, Aye Aye Thike, Wei Keat Wan, Puay Hoon Tan, Gyeong Hun Baeg
Oncotarget.2017; 8(70): 115370. CrossRef - Clinicopathologic implications of immune classification by PD-L1 expression and CD8-positive tumor-infiltrating lymphocytes in stage II and III gastric cancer patients
Jiwon Koh, Chan-Young Ock, Jin Won Kim, Soo Kyung Nam, Yoonjin Kwak, Sumi Yun, Sang-Hoon Ahn, Do Joong Park, Hyung-Ho Kim, Woo Ho Kim, Hye Seung Lee
Oncotarget.2017; 8(16): 26356. CrossRef
|
E-submission
